<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35608715</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1591-9528</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Clinical and experimental medicine</Title><ISOAbbreviation>Clin Exp Med</ISOAbbreviation></Journal><ArticleTitle>Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties.</ArticleTitle><Pagination><StartPage>679</StartPage><EndPage>688</EndPage><MedlinePgn>679-688</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10238-022-00836-x</ELocationID><Abstract><AbstractText>Hyperviscosity syndrome (HVS) recently emerged as a complication of coronavirus disease 2019 (COVID-19) and COVID-19 vaccines. Therefore, the objectives of this critical review are to establish the association between COVID-19 and COVID-19 vaccines with the development of HVS. HVS may develop in various viral infections due to impairment of humoral and cellular immunity with elevation of immunoglobulins. COVID-19 can increase blood viscosity (BV) through modulation of fibrinogen, albumin, lipoproteins, and red blood cell (RBC) indices. HVS can cause cardiovascular and neurological complications in COVID-19 like myocardial infarction (MI) and stroke. HVS with or without abnormal RBCs function in COVID-19 participates in the reduction of tissue oxygenation with the development of cardio-metabolic complications and long COVID-19. Besides, HVS may develop in vaccine recipients with previous COVID-19 due to higher underlying Ig concentrations and rarely without previous COVID-19. Similarly, patients with metabolic syndrome are at the highest risk for propagation of HVS after COVID-19 vaccination.&#xa0;In conclusion, COVID-19 and related vaccines are linked with the development of HVS, mainly in patients with previous COVID-19 and underlying metabolic derangements. The possible mechanism of HVS in COVID-19 and related vaccines is increasing levels of fibrinogen and immunoglobulins. However, dehydration, oxidative stress, and inflammatory reactions are regarded as additional contributing factors in the pathogenesis of HVS in COVID-19. However, this critical review cannot determine the final causal relationship between COVID-19 and related vaccines and the development of HVS. Prospective and retrospective studies are warranted in this field.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Kuraishy</LastName><ForeName>Hayder M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Gareeb</LastName><ForeName>Ali I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Bouseary</LastName><ForeName>Maisra M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0001-6503-0719</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Tanta University, Tanta, Egypt. maysra_mohamed@pharm.tanta.edu.eg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sonbol</LastName><ForeName>Fatma I</ForeName><Initials>FI</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batiha</LastName><ForeName>Gaber El-Saber</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, 22511, AlBeheira, Egypt. gaberbatiha@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Clin Exp Med</MedlineTA><NlmUniqueID>100973405</NlmUniqueID><ISSNLinking>1591-8890</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007136">Immunoglobulins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-32-5</RegistryNumber><NameOfSubstance UI="D005340">Fibrinogen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007136" MajorTopicYN="N">Immunoglobulins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007154" MajorTopicYN="Y">Immune System Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005340" MajorTopicYN="N">Fibrinogen</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccination</Keyword><Keyword MajorTopicYN="N">Hyperviscosity syndrome</Keyword></KeywordList><CoiStatement>The authors have no relevant financial or non-financial interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>24</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35608715</ArticleId><ArticleId IdType="pmc">PMC9128329</ArticleId><ArticleId IdType="doi">10.1007/s10238-022-00836-x</ArticleId><ArticleId IdType="pii">10.1007/s10238-022-00836-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rogers AP, Estes M. Hyperviscosity syndrome. StatPearls[internet]; 2021Jul21.</Citation></Reference><Reference><Citation>Owen RG, McCarthy H, Rule S, d&#x2019;Sa S, et al. Acalabrutinib monotherapy in patients with Waldenstr&#xf6;mmacroglobulinemia: a single-arm, multicentre, phase 2 study. Lancet Haematol. 2020;7(2):e112&#x2013;e121. doi: 10.1016/S2352-3026(19)30210-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(19)30210-8</ArticleId><ArticleId IdType="pubmed">31866281</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone MJ, Bogen SA. Evidence-based focused review of management of hyperviscosity syndrome. Blood. 2012;119(10):2205&#x2013;2208. doi: 10.1182/blood-2011-04-347690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-04-347690</ArticleId><ArticleId IdType="pubmed">22147890</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekelman J, Jackson N, Donehower R.&#xa0;Oncologic emergencies.&#xa0;2nd&#xa0;ed. Philadelphia: Saunders Elsevier; 2006.</Citation></Reference><Reference><Citation>Joob B, Wiwanitkit V. Expected viscosityafter COVID-19 vaccination, hyperviscosity and previous COVID-19. Clin ApplThromb Hemost. 2021 doi: 10.1177/10760296211020833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10760296211020833</ArticleId><ArticleId IdType="pmc">PMC8216419</ArticleId><ArticleId IdType="pubmed">34142570</ArticleId></ArticleIdList></Reference><Reference><Citation>Garderet L, Fabiani B, Lacombe K, Girard PM, Fl&#xe9;jou JF, Gorin NC. Hyperviscosity syndrome in an HIV-1&#x2014;positive patient. Am J Med. 2004;117(11):891&#x2013;893. doi: 10.1016/j.amjmed.2004.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2004.09.011</ArticleId><ArticleId IdType="pubmed">15589504</ArticleId></ArticleIdList></Reference><Reference><Citation>De Milito A, Nilsson A, Titanji K, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood. 2004;103(6):2180&#x2013;2186. doi: 10.1182/blood-2003-07-2375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-07-2375</ArticleId><ArticleId IdType="pubmed">14604962</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin DK, Nowakowski M, Kramer M, Essex DW. Hyperviscosity syndrome secondary to a myeloma-associated IgG1&#x3ba;paraprotein strongly reactive against the HIV-1 p24 gag antigen. AmJ Hematol. 2000;64(3):210&#x2013;213. doi: 10.1002/1096-8652(200007)64:3&lt;210::aid-ajh13&gt;3.0.co;2-#.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-8652(200007)64:3&lt;210::aid-ajh13&gt;3.0.co;2-#</ArticleId><ArticleId IdType="pubmed">10861819</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogomolov BP, Deviatkin AV. Microcirculation and hemostasis in influenza and acute viral respiratory infections complicated with pneumonia. Ter Arkh. 2002;74(3):44&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">11980121</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloop GD, De Mast Q, Pop G, Weidman JJ, St Cyr JA. The role of blood viscosity in infectious diseases. Cureus. 2020;12(2):e7090. doi: 10.7759/cureus.7090.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.7090</ArticleId><ArticleId IdType="pmc">PMC7096068</ArticleId><ArticleId IdType="pubmed">32226691</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi&#xf1;ol-Ripoll G, De La Puerta I, Santos S, Purroy F, Mostacero E. Chronic bronchitis and acute infections as new risk factors for ischemic stroke and the lack of protection offered by the influenza vaccination. CerebrovascDis. 2008;26(4):339&#x2013;347. doi: 10.1159/000151636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000151636</ArticleId><ArticleId IdType="pubmed">18728360</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wang K, Han LY, Li XH, Wang HM. Hemorheologic changes in patients with chronic hepatitis B.Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005;19(1):61&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">16201477</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson SG, Matthews KB, Cruickshank JK, Geddes AM, Stuart J. Coagulation activation and hyperviscosity in infection. BrJ Haematol. 1979;42(3):469&#x2013;480. doi: 10.1111/j.1365-2141.1979.tb01155.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.1979.tb01155.x</ArticleId><ArticleId IdType="pubmed">476000</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tong H, Van Ba N, Hoan NX, et al. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases. BMC Infect Dis. 2018;18(1):553. doi: 10.1186/s12879-018-3473-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-3473-2</ArticleId><ArticleId IdType="pmc">PMC6233598</ArticleId><ArticleId IdType="pubmed">30419833</ArticleId></ArticleIdList></Reference><Reference><Citation>Nwose EU. Whole blood viscosity assessment issues IV: Prevalence in acute phase inflammation. North Am J Med Sci. 2010;2(8):353&#x2013;358. doi: 10.4297/najms.2010.2353.</Citation><ArticleIdList><ArticleId IdType="doi">10.4297/najms.2010.2353</ArticleId><ArticleId IdType="pmc">PMC3339058</ArticleId><ArticleId IdType="pubmed">22737672</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JB, Baer AN. Hyperviscosity syndrome in rheumatoid arthritis. J Rheumatol. 2021;48(5):788&#x2013;789. doi: 10.3899/jrheum.200591.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.200591</ArticleId><ArticleId IdType="pubmed">33452169</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustine JN, Meid K, Dubeau T, et al. Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenstr&#xf6;mmacroglobulinaemia. Br J Haematol. 2017;177(5):717&#x2013;725. doi: 10.1111/bjh.14743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.14743</ArticleId><ArticleId IdType="pubmed">28485115</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokhandwala PM, Shabihkhani M, Ness PM, Bloch EM. Therapeutic plasma exchange for hyperviscosity syndrome secondary to high rheumatoid factor. Transfus ApherSci. 2018;57(2):225&#x2013;227. doi: 10.1016/j.transci.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transci.2018.02.004</ArticleId><ArticleId IdType="pubmed">29478798</ArticleId></ArticleIdList></Reference><Reference><Citation>CorriganIII FE, Leventhal AR, Khan S, Rao S, Christopher-Stine L, Schulman SP. A rare cause of cardiac ischemia: systemic lupus erythematosus presenting as the hyperviscosity syndrome. Ann Intern Med. 2010;153(6):422&#x2013;424. doi: 10.7326/0003-4819-153-6-201009210-00023.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-6-201009210-00023</ArticleId><ArticleId IdType="pubmed">20855816</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LY, Wong PC, Noda S, Collins DR, Sreenivasan GM, Coupland RC. Polyclonal hyperviscosity syndrome in IgG4-related disease and associated conditions. Clin Case Rep. 2015;3(4):217&#x2013;226. doi: 10.1002/ccr3.201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.201</ArticleId><ArticleId IdType="pmc">PMC4405305</ArticleId><ArticleId IdType="pubmed">25914812</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow A, Huggins M, Ahmed J, et al. CD169+ macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat Med. 2013;19(4):429&#x2013;436. doi: 10.1038/nm.3057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3057</ArticleId><ArticleId IdType="pmc">PMC3983996</ArticleId><ArticleId IdType="pubmed">23502962</ArticleId></ArticleIdList></Reference><Reference><Citation>Asano K, Kikuchi K, Tanaka M. CD169 macrophages regulate immune responses toward particulate materials in the circulating fluid. J Biochem. 2018;164(2):77&#x2013;85. doi: 10.1093/jb/mvy050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvy050</ArticleId><ArticleId IdType="pubmed">29905851</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Xia Y, Qiu CH. Functions of CD169 positive macrophages in human diseases (Review) Biomed Rep. 2021;14(2):26. doi: 10.3892/br.2020.1402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2020.1402</ArticleId><ArticleId IdType="pmc">PMC7780751</ArticleId><ArticleId IdType="pubmed">33408860</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetta HF, Mekky MA, Zahran AM, et al. Regulatory B cells and their cytokine profile in HCV-related hepatocellular carcinoma: association with regulatory T cells and disease progression. Vaccines. 2020;8(3):380. doi: 10.3390/vaccines8030380.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines8030380</ArticleId><ArticleId IdType="pmc">PMC7565874</ArticleId><ArticleId IdType="pubmed">32664587</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetta HF, Mwafey IM, Batiha GE, et al. CD19+ CD24hi CD38hi regulatory B cells and memory B cells in periodontitis: association with pro-inflammatory and anti-inflammatory cytokines. Vaccines. 2020;8(2):340. doi: 10.3390/vaccines8020340.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines8020340</ArticleId><ArticleId IdType="pmc">PMC7350217</ArticleId><ArticleId IdType="pubmed">32604936</ArticleId></ArticleIdList></Reference><Reference><Citation>Pop GAM, Hop WJ, Moraru L, et al. Blood electrical impedance closely matches whole blood viscosity as parameter of hemorheology and inflammation. Appl Rheol. 2003;13(6):305&#x2013;312. doi: 10.1515/arh-2003-0020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/arh-2003-0020</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordy MA, Pila EA, Hanington PC. The role of fibrinogen-related proteins in the gastropod immune response. Fish Shellfish Immunol. 2015;46(1):39&#x2013;49. doi: 10.1016/j.fsi.2015.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fsi.2015.03.005</ArticleId><ArticleId IdType="pubmed">25765166</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe5;hlman LI, M&#xf6;rgelin M, Kasetty G, Olin AI, Schmidtchen A, Herwald H. Antimicrobial activity of fibrinogen and fibrinogen-derived peptides&#x2013;a novel link between coagulation and innate immunity. Thromb Haemost. 2013;109(5):930&#x2013;939. doi: 10.1160/TH12-10-0739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH12-10-0739</ArticleId><ArticleId IdType="pubmed">23467586</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Cruz-Martins N, Batiha GE. The potential role of neopterin in Covid-19: a new perspective. Mol Cell Biochem. 2021;476(11):4161&#x2013;4166. doi: 10.1007/s11010-021-04232-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-021-04232-z</ArticleId><ArticleId IdType="pmc">PMC8317144</ArticleId><ArticleId IdType="pubmed">34319496</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Alexiou A, Batiha GE. Niclosamide for Covid-19: bridging the gap. MolBiolRep. 2021;48(12):8195&#x2013;8202. doi: 10.1007/s11033-021-06770-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-021-06770-7</ArticleId><ArticleId IdType="pmc">PMC8522539</ArticleId><ArticleId IdType="pubmed">34664162</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy HM, Al-Gareeb AI, Almulaiky YQ, Cruz-Martins N, El-Saber Batiha GE. Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: the enigmatic entity. EurJ Pharmacol. 2021;904:174196. doi: 10.1016/j.ejphar.2021.174196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2021.174196</ArticleId><ArticleId IdType="pmc">PMC8123523</ArticleId><ArticleId IdType="pubmed">34004207</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy HM, Al-Gareeb AI, Alkazmi L, Alexiou A, Batiha GE. Levamisoletherapy in COVID-19. Viral Immunol. 2021;34(10):722&#x2013;725. doi: 10.1089/vim.2021.0042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2021.0042</ArticleId><ArticleId IdType="pubmed">34388031</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy HM, Al-Gareeb AI, Alqarni M, Cruz-Martins N, El-Saber BG. Pleiotropic effects of tetracyclines in the management of COVID-19: emergingperspectives. Front Pharmacol. 2021;12:642822. doi: 10.3389/fphar.2021.642822.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.642822</ArticleId><ArticleId IdType="pmc">PMC8103613</ArticleId><ArticleId IdType="pubmed">33967777</ArticleId></ArticleIdList></Reference><Reference><Citation>Batiha GE, Shaheen HM, Al-Kuraishy HM, et al. Possible mechanistic insights into iron homeostasis role of the action of 4-aminoquinolines (chloroquine/hydroxychloroquine) on COVID-19 (SARS-CoV-2) infection. Eur Rev Med Pharmacol Sci. 2021;25(23):7565&#x2013;7584. doi: 10.26355/eurrev_202112_27456.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202112_27456</ArticleId><ArticleId IdType="pubmed">34919258</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy HM, Al-Gareeb AI, El-Saber Batiha GE. The possible role of ursolic acid in Covid-19: a real game changer. Clin Nutr ESPEN. 2022;47:414&#x2013;417. doi: 10.1016/j.clnesp.2021.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.12.030</ArticleId><ArticleId IdType="pmc">PMC8724013</ArticleId><ArticleId IdType="pubmed">35063236</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy HM, Al-Gareeb AI, Faidah H, Al-Maiahy TJ, Cruz-Martins N, Batiha GE. The looming effects of estrogen in Covid-19: a rocky rollout. Front Nutr. 2021;8:649128. doi: 10.3389/fnut.2021.649128.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.649128</ArticleId><ArticleId IdType="pmc">PMC8012689</ArticleId><ArticleId IdType="pubmed">33816542</ArticleId></ArticleIdList></Reference><Reference><Citation>Renoux C, Fort R, Nader E, et al. Impact of COVID-19 on red blood cell rheology. Br J Haematol. 2021;192(4):e108&#x2013;e111. doi: 10.1111/bjh.17306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.17306</ArticleId><ArticleId IdType="pubmed">33410504</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehr HA, Bittinger F, Kirkpatrick CJ. Microcirculatory dysfunction in sepsis: A pathogenetic basis for therapy? J Pathol. 2000;190(3):373&#x2013;386. doi: 10.1002/(SICI)1096-9896(200002)190:3&lt;373::AID-PATH593&gt;3.0.CO;2-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9896(200002)190:3&lt;373::AID-PATH593&gt;3.0.CO;2-3</ArticleId><ArticleId IdType="pubmed">10685071</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundy DJ, Trzeciak S. Microcirculatory dysfunction in sepsis. Crit Care Nurs Clin North Am. 2011;23(1):67&#x2013;77. doi: 10.1016/j.ccell.2010.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2010.12.004</ArticleId><ArticleId IdType="pubmed">21316568</ArticleId></ArticleIdList></Reference><Reference><Citation>Colantuoni A, Martini R, Caprari P, et al. COVID-19 sepsis and microcirculation dysfunction. Front Physiol. 2020;26(11):747. doi: 10.3389/fphys.2020.00747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00747</ArticleId><ArticleId IdType="pmc">PMC7333313</ArticleId><ArticleId IdType="pubmed">32676039</ArticleId></ArticleIdList></Reference><Reference><Citation>Joob B, Wiwanitkit V. Blood viscosity of COVID-19 patient: a preliminary report. Am J Blood Res. 2021;11(1):93&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010604</ArticleId><ArticleId IdType="pubmed">33796395</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SK, Slim EJ, De Kruif MD, et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med. 2005;63(4):129&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">15869040</ArticleId></ArticleIdList></Reference><Reference><Citation>Venter C, Bezuidenhout JA, Laubscher GJ, et al. Erythrocyte, platelet, serum ferritin, and p-selectin pathophysiology implicated in severe hypercoagulation and vascular complications in COVID-19. Int J Mol Sci. 2020;21(21):8234. doi: 10.3390/ijms21218234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218234</ArticleId><ArticleId IdType="pmc">PMC7662625</ArticleId><ArticleId IdType="pubmed">33153161</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Atanu FO, Batiha GE. Arginine vasopressin and pathophysiology of COVID-19: an innovative perspective. Biomed Pharmacother. 2021;143:112193. doi: 10.1016/j.biopha.2021.112193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112193</ArticleId><ArticleId IdType="pmc">PMC8440235</ArticleId><ArticleId IdType="pubmed">34543987</ArticleId></ArticleIdList></Reference><Reference><Citation>Alamri HS, Alsughayyir J, Akiel M, et al. Stimulation of calcium influx and CK1&#x3b1; by NF-&#x3ba;B antagonist [6]-gingerol reprograms red blood cell longevity. J Food Biochem. 2021;45(1):e13545. doi: 10.1111/jfbc.13545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jfbc.13545</ArticleId><ArticleId IdType="pubmed">33145778</ArticleId></ArticleIdList></Reference><Reference><Citation>Nader E, Romana M, Connes P. The red blood cell&#x2014;inflammation vicious circle in sickle cell disease. Front Immunol. 2020;11:454. doi: 10.3389/fimmu.2020.00454.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00454</ArticleId><ArticleId IdType="pmc">PMC7082402</ArticleId><ArticleId IdType="pubmed">32231672</ArticleId></ArticleIdList></Reference><Reference><Citation>Batiha GE, Al-Gareeb DAI, Qusti S, et al. Common NLRP3 inflammasome inhibitors and Covid-19: divide and Conquer. Sci Afr. 2021 doi: 10.1016/j.sciaf.2021.e01084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sciaf.2021.e01084</ArticleId><ArticleId IdType="pmc">PMC8683381</ArticleId><ArticleId IdType="pubmed">34957352</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedin AS, Makinson A, Picot MC, et al. Monocyte CD169 expression as a biomarker in the early diagnosis of coronavirus disease 2019. J Infect Dis. 2021;223(4):562&#x2013;567. doi: 10.1093/infdis/jiaa724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa724</ArticleId><ArticleId IdType="pmc">PMC7717347</ArticleId><ArticleId IdType="pubmed">33206973</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GE. Neutrophil extracellular traps (NETs) and Covid-19: a new frontiers for therapeutic modality. IntImmunopharmacol. 2022;104:108516. doi: 10.1016/j.intimp.2021.108516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108516</ArticleId><ArticleId IdType="pmc">PMC8733219</ArticleId><ArticleId IdType="pubmed">35032828</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738&#x2013;1742. doi: 10.1111/jth.14850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14850</ArticleId><ArticleId IdType="pmc">PMC9906150</ArticleId><ArticleId IdType="pubmed">32302438</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozkan S, Cakmak F, Konukoglu D, et al. Efficacy of serumangiotensin IIlevels in prognosis of patients with coronavirus Disease 2019. Crit Care Med. 2021 doi: 10.1097/CCM.0000000000004967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004967</ArticleId><ArticleId IdType="pubmed">33630767</ArticleId></ArticleIdList></Reference><Reference><Citation>Buyan N, Ak&#xe7;aboy M, G&#xf6;kta&#x15f; T, et al. Effects of whole blood viscosity and plasma NOx on cardiac function and cerebral blood flow in children with chronic kidney disease. Turk J Med Sci. 2017;47(5):1482&#x2013;1491. doi: 10.3906/sag-1609-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-1609-33</ArticleId><ArticleId IdType="pubmed">29151320</ArticleId></ArticleIdList></Reference><Reference><Citation>Violi F, Ceccarelli G, Cangemi R, et al. Hypoalbuminemia, coagulopathy, and vascular disease in COVID-19. Circ Res. 2020;127(3):400&#x2013;401. doi: 10.1161/CIRCRESAHA.120.317173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317173</ArticleId><ArticleId IdType="pubmed">32508261</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi X, Su Z, Yan H, et al. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin ratio and Platelet count. Platelets. 2020;31(5):674&#x2013;679. doi: 10.1080/09537104.2020.1760230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09537104.2020.1760230</ArticleId><ArticleId IdType="pmc">PMC7212543</ArticleId><ArticleId IdType="pubmed">32367765</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali MAM, Spinler SA. COVID-19 and thrombosis: from bench to bedside. Trends Cardiovasc Med. 2021;31(3):143&#x2013;160. doi: 10.1016/j.tcm.2020.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.12.004</ArticleId><ArticleId IdType="pmc">PMC7836332</ArticleId><ArticleId IdType="pubmed">33338635</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Felicetti L, Femminella M, Reali G. A molecular communications system for live detection of hyperviscosity syndrome. IEEE Trans Nanobioscience. 2020;19(3):410&#x2013;421. doi: 10.1109/TNB.2020.2984880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TNB.2020.2984880</ArticleId><ArticleId IdType="pubmed">32248117</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich H, Pillat MM. CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement. Stem Cell Rev Rep. 2020;16(3):434&#x2013;440. doi: 10.1007/s12015-020-09976-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-09976-7</ArticleId><ArticleId IdType="pmc">PMC7167302</ArticleId><ArticleId IdType="pubmed">32307653</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosic I, Cosic D, Loncarevic I. RRM prediction of erythrocyte Band3 protein as alternative receptor for SARS-CoV-2 virus. Appl Sci. 2020;10(11):4053. doi: 10.3390/app10114053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app10114053</ArticleId></ArticleIdList></Reference><Reference><Citation>Foy BH, Carlson JCT, Reinertsen E, et al. Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection. JAMA Netw Open. 2020 doi: 10.1001/jamanetworkopen.2020.22058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.22058</ArticleId><ArticleId IdType="pmc">PMC7512057</ArticleId><ArticleId IdType="pubmed">32965501</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavanagh BD, Coffey BE, Needham D, Hochmuth RM, Dewhirst MW. The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment. BrJ Cancer. 1993;67(4):734&#x2013;741. doi: 10.1038/bjc.1993.134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.1993.134</ArticleId><ArticleId IdType="pmc">PMC1968366</ArticleId><ArticleId IdType="pubmed">8471430</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloop GD, Garber DW. The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans. Clin Sci (Lond) 1997;92(5):473&#x2013;479. doi: 10.1042/cs0920473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/cs0920473</ArticleId><ArticleId IdType="pubmed">9176020</ArticleId></ArticleIdList></Reference><Reference><Citation>Meurs I, Hoekstra M, van Wanrooij EJ, et al. HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes. Exp Hematol. 2005;33(11):1309&#x2013;1319. doi: 10.1016/j.exphem.2005.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exphem.2005.07.004</ArticleId><ArticleId IdType="pubmed">16263415</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, De Tymowski C, Assadi M, et al. Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: results from the ApoCOVID study. PLoS ONE. 2020;15(9):e0239573. doi: 10.1371/journal.pone.0239573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239573</ArticleId><ArticleId IdType="pmc">PMC7514065</ArticleId><ArticleId IdType="pubmed">32970772</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Chen D, Wu L, He G, Ye W. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clin Chim Acta. 2020;510:105&#x2013;110. doi: 10.1016/j.cca.2020.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.07.015</ArticleId><ArticleId IdType="pmc">PMC7350883</ArticleId><ArticleId IdType="pubmed">32653486</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R, Mamun A, Dominic A, Le NT. SARS-CoV-2 mediated endothelial dysfunction: the potential role of chronic oxidative stress. Front Physiol. 2020;11:1752. doi: 10.3389/fphys.2020.605908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.605908</ArticleId><ArticleId IdType="pmc">PMC7844210</ArticleId><ArticleId IdType="pubmed">33519510</ArticleId></ArticleIdList></Reference><Reference><Citation>Becatti M, Marcucci R, Gori AM, et al. Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion. J Thromb Haemost. 2016;14(11):2287&#x2013;2297. doi: 10.1111/jth.13482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13482</ArticleId><ArticleId IdType="pubmed">27557753</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortaz E, Malkmohammad M, Jamaati H, et al. Silent hypoxia: higherNO in red blood cells of COVID-19 patients. BMC PulmMed. 2020;20(1):269. doi: 10.1186/s12890-020-01310-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-020-01310-8</ArticleId><ArticleId IdType="pmc">PMC7563910</ArticleId><ArticleId IdType="pubmed">33066765</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahdi A, Collado A, Tengbom J, et al. Erythrocytes induce vascular dysfunction in COVID-19. Eur Heart J. 2021 doi: 10.1093/eurheartj/ehab724.3364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab724.3364</ArticleId><ArticleId IdType="pmc">PMC8849181</ArticleId><ArticleId IdType="pubmed">35194565</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu W, Wang C, Zou L, et al. Psychological health, sleep quality, and coping styles to stress facing the COVID-19 in Wuhan, China. Transl Psychiatry. 2020;10(1):225. doi: 10.1038/s41398-020-00913-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-020-00913-3</ArticleId><ArticleId IdType="pmc">PMC7347261</ArticleId><ArticleId IdType="pubmed">32647160</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong JH, Hanevold C, Harris RA, et al. Angiotensin II receptor blocker attenuates stress pressor response in young adult African Americans. J Clin Hypertens (Greenwich) 2019;21(8):1191&#x2013;1199. doi: 10.1111/jch.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jch.13625</ArticleId><ArticleId IdType="pmc">PMC6690765</ArticleId><ArticleId IdType="pubmed">31328876</ArticleId></ArticleIdList></Reference><Reference><Citation>Tekin Tak B, Ekizler FA, Cay S, et al. Relationship between apical thrombus formation and blood viscosity in acute anterior myocardial infarction patients. Biomark Med. 2020;14(3):201&#x2013;210. doi: 10.2217/bmm-2019-0483.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2019-0483</ArticleId><ArticleId IdType="pubmed">31912743</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CH, Jung KH, Cho DJ, Jeong SK. Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial. BMC Neurol. 2019;19(1):82. doi: 10.1186/s12883-019-1315-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-019-1315-5</ArticleId><ArticleId IdType="pmc">PMC6495650</ArticleId><ArticleId IdType="pubmed">31043158</ArticleId></ArticleIdList></Reference><Reference><Citation>Lala A, Johnson KW, Januzzi JL, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol. 2020;76(5):533&#x2013;546. doi: 10.1016/j.jacc.2020.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7279721</ArticleId><ArticleId IdType="pubmed">32517963</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong AD, Auld SC, Barker NA, et al. Therapeutic plasma exchange for COVID-19-associated hyperviscosity. Transfusion. 2021;61(4):1029&#x2013;1034. doi: 10.1111/trf.16218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.16218</ArticleId><ArticleId IdType="pmc">PMC7753437</ArticleId><ArticleId IdType="pubmed">33231313</ArticleId></ArticleIdList></Reference><Reference><Citation>Song WC, FitzGerald GA. COVID-19, microangiopathy, hemostatic activation, and complement. J Clin Invest. 2020;130(8):3950&#x2013;3953. doi: 10.1172/JCI140183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140183</ArticleId><ArticleId IdType="pmc">PMC7410042</ArticleId><ArticleId IdType="pubmed">32459663</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloop GD, Pop GA, Weidman JJ, Cyr JA. The detrimental role of elevated blood viscosity in patients with COVID-19. Cardiol Ther. 2021;8(1):976&#x2013;980.</Citation></Reference><Reference><Citation>Maier CL, Truong AD, Auld SC, Polly DM, Tanksley CL, Duncan A. COVID-19-associated hyperviscosity: A link between inflammation and thrombophilia? Lancet. 2020;395(10239):1758&#x2013;1759. doi: 10.1016/S0140-6736(20)31209-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31209-5</ArticleId><ArticleId IdType="pmc">PMC7247793</ArticleId><ArticleId IdType="pubmed">32464112</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenz C, Rebel A, Waschke KF, Koehler RC, Frietsch T. Blood viscosity modulates tissue perfusion&#x2013;sometimes and somewhere. Transfus Altern Transfus Med. 2008;9(4):265&#x2013;272. doi: 10.1111/j.1778-428X.2007.00080.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1778-428X.2007.00080.x</ArticleId><ArticleId IdType="pmc">PMC2519874</ArticleId><ArticleId IdType="pubmed">19122878</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubieta-Calleja G, Zubieta-DeUrioste N. Pneumolysis and &#x201d;silent hypoxemia&#x201d; in COVID-19. Indian J Clin Biochem. 2021;36(1):112&#x2013;116. doi: 10.1007/s12291-020-00935-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12291-020-00935-0</ArticleId><ArticleId IdType="pmc">PMC7652053</ArticleId><ArticleId IdType="pubmed">33191989</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne T, Crewther S, Post C. Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J NeurolSci. 2020;419:117179. doi: 10.1016/j.jns.2020.117179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117179</ArticleId><ArticleId IdType="pmc">PMC7550857</ArticleId><ArticleId IdType="pubmed">33070003</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B, Larson C, Hammond TC, et al. A review of persistent post-COVID syndrome (PPCS) Clin Rev Allergy Immunol. 2021 doi: 10.1007/s12016-021-08848-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurol Sci. 2020;21:100276. doi: 10.1016/j.ensci.2020.100276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2020.100276</ArticleId><ArticleId IdType="pmc">PMC7502253</ArticleId><ArticleId IdType="pubmed">32984564</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Thanh T, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305&#x2013;306. doi: 10.1038/d41573-020-00073-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41573-020-00073-5</ArticleId><ArticleId IdType="pubmed">32273591</ArticleId></ArticleIdList></Reference><Reference><Citation>Khon K, Mungmungpuntipantip R, Wiwanitkit V. Post COVID-19 vaccination, increased blood viscosity and impact on laboratory investigation results. Sri Lanka J Child Health. 2021;50(4):747. doi: 10.4038/sljch.v50i4.9908.</Citation><ArticleIdList><ArticleId IdType="doi">10.4038/sljch.v50i4.9908</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalakas MC. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology. 1994;44(2):223&#x2013;226. doi: 10.1212/wnl.44.2.223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.44.2.223</ArticleId><ArticleId IdType="pubmed">8309562</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasri S, Wiwanitkit V. COVID-19 vaccine, contraceptive, viscosity and safety margin change. Vaccine. 2021;1:0&#x2013;92.</Citation></Reference><Reference><Citation>Irace C, Scavelli F, Carallo C, Serra R, Gnasso A. Plasma and blood viscosity in metabolic syndrome. Nutr Metab Cardiovasc Dis. 2009;19(7):476&#x2013;480. doi: 10.1016/j.numecd.2008.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2008.11.005</ArticleId><ArticleId IdType="pubmed">19201176</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyawali P, Richards RS, Nwose EU, Bwititi PT. Whole-blood viscosity and metabolic syndrome. Clin Lipidol. 2012;7(6):709&#x2013;719. doi: 10.2217/clp.12.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/clp.12.65</ArticleId></ArticleIdList></Reference><Reference><Citation>Joob B, Wiwanitkit V. Change of blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome. IntJ Physiol Pathophysiol Pharmacol. 2021;13(5):148&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611240</ArticleId><ArticleId IdType="pubmed">34868465</ArticleId></ArticleIdList></Reference><Reference><Citation>Long DS, Smith ML, Pries AR, Ley K, Damiano ER. Microviscometry reveals reduced blood viscosity and altered shear rate and shear stress profiles in microvessels after hemodilution. Proc Natl Acad Sci U S A. 2004;101(27):10060&#x2013;10065. doi: 10.1073/pnas.0402937101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402937101</ArticleId><ArticleId IdType="pmc">PMC454164</ArticleId><ArticleId IdType="pubmed">15220478</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma O, Sultan AA, Ding H, Triggle CR. A review of the progress and challenges of developing a vaccine for COVID-19. Front Immunol. 2020;11:585354. doi: 10.3389/fimmu.2020.585354.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.585354</ArticleId><ArticleId IdType="pmc">PMC7591699</ArticleId><ArticleId IdType="pubmed">33163000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sookaromdee P, Wiwanitkit V. COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem. Ann Hepatol. 2021;24:100525. doi: 10.1016/j.aohep.2021.100525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aohep.2021.100525</ArticleId><ArticleId IdType="pmc">PMC8425075</ArticleId><ArticleId IdType="pubmed">34509271</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Onofrio L, Coraggio L, Zurru A, et al. Short-term safety profile of Sars-Cov2 vaccination on glucose control: continuous glucose monitoring data in people with autoimmune diabetes. Diabetes Res Clin Pract. 2021;179:109022. doi: 10.1016/j.diabres.2021.109022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2021.109022</ArticleId><ArticleId IdType="pmc">PMC8383474</ArticleId><ArticleId IdType="pubmed">34450248</ArticleId></ArticleIdList></Reference><Reference><Citation>Nwose EU, Richards RS, Bwititi P, Butkowski E. Serum bilirubin and lipoprotein-a: how are these associated with whole blood viscosity? Redox Rep. 2012;17(1):8&#x2013;13. doi: 10.1179/1351000211Y.0000000017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1351000211Y.0000000017</ArticleId><ArticleId IdType="pmc">PMC6837361</ArticleId><ArticleId IdType="pubmed">22340510</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752&#x2013;1761. doi: 10.1172/JCI21625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI21625</ArticleId><ArticleId IdType="pmc">PMC535065</ArticleId><ArticleId IdType="pubmed">15599400</ArticleId></ArticleIdList></Reference><Reference><Citation>Sol&#xe1; E, Vay&#xe1; A, Sim&#xf3; M, et al. Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance. Clin Hemorheol Microcirc. 2007;37(4):309&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">17942983</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivonello C, Negri M, Pivonello R, Colao A. How may obesity-induced oxidative stress affect the outcome of COVID-19 accines? Lesson Learn Infect Stresses. 2021;1(2):119&#x2013;122.</Citation></Reference><Reference><Citation>Painter SD, Ovsyannikova IG, Poland GA. The weight of obesity on the human immune response to vaccination. Vaccine. 2015;33(36):4422&#x2013;4429. doi: 10.1016/j.vaccine.2015.06.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.06.101</ArticleId><ArticleId IdType="pmc">PMC4547886</ArticleId><ArticleId IdType="pubmed">26163925</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>